Snapshot from Jul 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Quantum BioPharma retains FinnCom
Business corporate update

Quantum BioPharma retains FinnCom

Analysis based on 6 articles · First reported Jul 07, 2026 · Last updated Jul 07, 2026

Sentiment
0
Attention
0
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

This is a minor corporate update with limited market impact. The retention of a marketing firm suggests efforts to increase investor awareness, but the financial commitment is relatively small.

biotechnology pharmaceutical
Event Summary

Quantum BioPharma Ltd. announced on July 7, 2026 that it has retained FinnCom, Inc. to provide marketing and investor awareness services under a six-month contract starting June 24, 2026, with an option for renewal. The agreement includes an initial payment of USD 20,500 and six monthly payments of USD 25,000, totaling USD 170,500. FinnCom is an arm's-length firm based in Lancaster, California, and does not own any shares in Quantum BioPharma. The company also provided background on its subsidiaries Lucid Psycheceuticals Inc. Inc. and Unbuzzd Wellness Inc. Inc., and its lead compound Lucid-MS.

Key Actions
30 Quantum BioPharma retained FinnCom
Entities Involved
priv
Quantum BioPharma
Quantum BioPharma is the company announcing the retention of FinnCom for marketing services. The event is a routine corporate update with no material impact on its operations or financials.
Importance 100.0 Sentiment 0.0
priv
FinnCom
FinnCom is the marketing firm retained by Quantum BioPharma. The contract provides FinnCom with USD 170,500 in revenue over six months.
Importance 80.0 Sentiment 0.0
curr
United States — United States dollar
The United States — United States dollar is the currency used for the contract payments. It is mentioned as the denomination of the financial terms.
Importance 10.0 Sentiment 0.0
priv
Lucid Psycheceuticals Inc.
Lucid Psycheceuticals Inc. is a wholly owned subsidiary of Quantum BioPharma focused on Lucid-MS. It is mentioned in the background but not directly involved in the event.
Importance 10.0 Sentiment 0.0
priv
Unbuzzd Wellness Inc.
Unbuzzd Wellness Inc. Inc. is a company spun out from Quantum BioPharma, in which Quantum BioPharma retains a 19.84% stake and royalty rights. It is mentioned in the background but not directly involved in the event.
Importance 10.0 Sentiment 0.0
per
Zeeshan Saeed
Zeeshan Saeed is the Founder, CEO and Executive Co-Chairman of Quantum BioPharma. He is listed as a contact but not directly involved in the event.
Importance 10.0 Sentiment 0.0
per
Kevin Finn
Kevin Finn is the contact person for FinnCom. He is mentioned as a contact but not directly involved in the event.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.